THERAPEUTIC CATEGORIES
ANTI-ALLERGIC
SL Product Formula Form 1 Levocetirizine Hydrochloride & Montelukast Tablets Each uncoated tablet contains Levocetirizine Hydrochloride IP : 2.5 mg Montelukast Sodium IP equivalent to Montelukast : 4 mg Excipient : qs Tablet 2 Montelukast & Levocetrizine Hydrochloride Tablets Each uncoated bi-layered tablet contains Montelukas Sodium IP equivalent to Montelukast : 10 mg Levocetrizine Hydrochloride IP : 5 mg Colour : Erythrosine Supra & Tartrazine Supra Excipients : qs Tablet 3 Cetirizine Tablets IP 10 mg Each film coated tablet contains Cetirizine Hydrochloride IP : 10 mg Colour : Titanium Dioxide Excipients : qs Tablet 4 Levocetirizine tablets IP 5 mg Each film coated tablet contains Levocetirizine Hydrochloride IP : 5 mg Colour : Titanium Dioxide Excipients : qs Tablet 5 Fexofenadine Tablets IP 120 mg Each film coated tablet contains Fexofenadine Hydrochloride IP : 120 mg Colour : Titanium Dioxide Excipients : qs Tablet 6 Fexofenadine Tablets IP 180 mg Each film coated tablet contains Fexofenadine Hydrochloride IP : 180 mg Colour : Titanium Dioxide & Iron Oxide Red Excipients : qs Tablet 7 Levocetirizine Tablets 10 mg Each film coated tablet contains Levocitirizine Hydrochloride IP : 10 mg Colour : Brilliant blue Excipients : qs Tablet 8 Montelukast Tablets IP 10 mg Each film coated tablet contains Montelukast Sodium IP equivalent to Montelukast 10 mg Color : Titanium Dioxide & Iron oxide Red Excipients : qs Tablet 9 Phenyl Ephrine Hydrochloride & Chlorphniramine Maleate drops Each ml contains Phenyl Ephrine Hydrochloride IP : 5 mg Chlorpheniramine Maleate IP : 2 mg Flavoured syrup base : qs Colour : Sunset Yellow FCF Oral Liquids 10 Levosalbutamol Syrup Each 5 ml contains Levosalbutamol Sulphate IP equivalent to Levosalbutamol : 1 mg Colour : Sunset Yellow FCF Flavoured syrup base Oral Liquids 11 Doxofylline Tablets IP 400 mg Each uncoated tablet contains Doxofylline IP : 400 mg Excipients : qs Tablet ANTIBIOTICS
SL Product Formula Form 1 Ciprofloxacin Tablets IP 250 mg Each film coated tablet contains Ciprofloxacin Hydrochloride IP equivalent to Ciprofloxacin : 250 mg Colour : Titanium Dioxide Excipients : qs Tablet 2 Ciprofloxacin Tablets IP 500 mg Each film coated tablet contains Ciprofloxacin Hydrochloride IP equivalent to Ciprofloxacin : 500 mg Colour : Titanium Dioxide Excipients : qs Tablet 3 Levofloxacin Tablets IP 500 mg Each film coated tablet contains Levofloxacin Hemihydrate IP equivalent to Levofloxacin 500 mg Colour : Titanium Dioxide & Iron Oxide red Excipients : qs Tablet 4 Ciprofloxacin Eye/Ear Drops 0.3% w/v Ciprofloxacin Hydrochloride USP equivalent to Ciprofloxacin 0.3% w/v Benzalkonium Chloride solution USNF 0.02% w/v Sterile aqueous buffered vehicle : qs Eye/Ear Drops 5 Ofloxacin Eye/Ear Drops 0.3% w/v Ofloxacin IP : 0.3% w/v Benzalkonium Chloride solution IP : 0.0 2% w/v Sterile aqueous vehicle : qs Drops 6 Chloramphenicol 0.5% Ophthalmic Solution USP Chloramphenicol USP 0.5% w/v Phenyl Mercuric Nitrate BP 0.001% w/v Sterile aqueous buffered vehicle : qs Eye Drop 7 Erythromycin Stearate Tablets IP 250 mg Each film coated tablet contains Erythromycin Stearate IP equivalent to Erythromycin 250 mg Colour : Erythrocine Excipients : qs Tablet 8 Azithromycin Oral Suspension 100 mg Each 5 ml contains Azithromycin Dihydrate IP equivalent to Azithromycin anhydrous : 100 mg Flavoured syrup base Colour : Erythrosine Oral Liquids 9 Azithromycin Oral Suspension IP 200 mg Each 5 ml contains Azithromycin Dihydrate IP equivalent to Azithromycin anhydrous : 200 mg Colour : Sunset yellow Oral Liquids 10 Gatifloxacin Eye Drops 0.3% w/v Gatifloxacin IP : 0.3% w/v Benzalkonium Chloride solution IP : 0.02% v/v Sterile aqueous vehicle : qs Drops 11 Gentamycin Eye Drops 0.3% w/v Gentamicin sulphate IP equivalent to Gentamicin 0.3% w/v Benzalkonium Chloride solution IP : 0.02% w/v Sterile aqueous buffered vehicle : qs Drops 12 Levofloxacin Eye/Ear Drops 0.5% w/v Levofloxacin Hemihydrate IP equivalent to Levofloxacin : 0.5% w/v Benzalkonium Chloride solution IP : 0.02% v/v Sterile aqueous vehicle : qs Drops 13 Tobramycin Eye/Ear Drops 0.3% w/v Composition : Tobramycin Sulfate USP equivalent to Tobramycin : 0.3% w/v Benzalkonium Chloride solution IP : 0.02% v/v Sterile aqueous vehicle : qs Eye/Ear Drops 14 Moxifloxacin Eye Drops 0.5% w/v Moxifloxacin Hydrochloride IP equivalent to Moxifloxacin : 0.5% w/v Sterile aqueous vehicle : qs Eye Drops 15 Azithromycin Tablets IP 250 mg Each film coated tablet contains Azithromycin Dihydrate IP equivalent to Azithromycin anhydrous : 250 mg Colour : Titanium Dioxide Excipients : qs Tablet 16 Azithromycin Tablets IP 500 mg Each film coated tablet contains Azithromycin Dihydrate IP equivalent to Azithromycin anhydrous : 500 mg Colour : Titanium Dioxide Excipients : qs Tablet ANTI-DEPRESSANT
SL Product Formula Form 1 Amitriptyline Tablets IP 10 mg Each film coated tablet contains Amitryptyline Hydrochloride IP : 10 mg Colour : Titanium Dioxide Excipients : qs Tablet 2 Dosulepin Tablets BP 25 mg (Formerly Dothiepin Tablets BP) Each film coated tablet contains Dothiepin Hydrochloride IP : 25 mg Colour : Sunset yellow lake Excipients : qs Tablet 3 Dosulepin Tablets BP 50 mg (Formerly Dothiepin Tablets BP) Each film coated tablet contains Dothiepin Hydrochloride IP : 50 mg Colour : Sunset yellow lake Excipients : qs Tablet 4 Dosulepin Tablets BP 75 mg (Formerly Dothiepin Tablets BP) Each film coated tablet contains Dothiepin Hydrochloride IP : 75 mg Colour : Sunset yellow lake Excipients : qs Tablet ANTI-DIABETIC
SL Product Formula Form 1 Glimepiride Tablets IP 1 mg Each uncoated tablet contains Glimepiride IP : 1 mg Excipients : qs Tablet 2 Glimepiride Tablets IP 2 mg Each uncoated tablet contains Glimepiride IP : 2 mg Excipients : qs Colour : Sunset yellow FCF supra Tablet 3 Metformin Hydrochloride prolonged release tablets IP 1000 mg Each uncoated prolonged release tablet contains Metformin Hydrochloride IP : 1000 mg Excipients : qs Tablet 4 Metformin Tablets IP 500 mg Each uncoated tablet contains Metformin Hydrochloride IP : 500 mg Excipients : qs Tablet 5 Metformin Hydrochloride prolonged release Tablets IP 500 mg Each film coated bi-layered tablet contains Metformin Hydrochloride IP : 500 mg Colour : Brilliant blue FCF Excipients : qs Tablet 6 Teneligliptin Tablets 20 mg Each film coated tablet contains Teneligliptin Hydrobromide Hydrate equivalent to Teneligliptin : 20 mg Colour : Yellow Oxide of Iron Excipients : qs Tablet 7 Metformin Hydrochloride & Gliclazide Tablets Each uncoated tablet contains Metformin Hydrochloride IP : 500 mg Gliclazide IP : 80 mg Excipients : qs Tablet 8 Metformin Hydrochloride 500 mg (sustained release) & Glimepiride 1 mg Tablets Each uncoated bi-layered tablet contains Metformin Hydrochloride IP : 500 mg Glimepiride IP : 1 mg Colour : Sunset yellow Excipients : qs Tablet 9 Metformin Hydrochloride 500 mg (sustained release) & Glimepiride 2 mg Tablets Each uncoated bi-layered tablet contains Metformin Hydrochloride IP : 500 mg Glimepiride IP : 2 mg Colour : Quinoline yellow Excipients : qs Tablet 10 Glimepiride, Voglibose & Metformin (SR) Tablets Each uncoated bi-layered tablet contains Glimepiride IP : 1 mg Voglibose IP : 0.2 mg Metformin Hydrochloride IP : 500 mg (as sustained release) Colour : Red Oxide of Iron Tablet 11 Glimepiride, Voglibose & Metformin (ER) Tablets Each uncoated bi-layered tablet contains Glimepiride IP : 2 mg Voglibose IP : 0.2 mg Metformin Hydrochloride IP : 500 mg (as extended release) Colour : Yellow Oxide of Iron Excipients : qs Tablet ANTIEMETICS
SL Product Formula Form 1 Doxylamine Succinate & Pyridoxine Hydrochloride Tablets Each enteric coated tablet contains Doxylamine Succinate USP : 20 mg Pyridoxine Hydrochloride (Vitamin B6) IP : 20 mg Colour : Tartrazine yellow lake & Titanium Dioxide IP Excipients : qs Tablet ANTI-FUNGAL
SL Product Formula Form 1 Fluconazole Tablets IP 150 mg Each uncoated tablet contains Fluconazole IP : 150 mg Excipients : qs Tablet ANTI-GLAUCOMA
SL Product Formula Form 1 Timolol 0.5% Opthalmic solution BP Timolol Maleate BP equivalent to Timolol : 0.5% w/v Benzalkonium Chloride BP : 0.01% w/v Sterile aqueous buffered vehicle : qs Drops ANTI-HYPERURICEMIC
SL Product Formula Form 1 Febuxostat Tablets 20 mg Each filmcoated tablet contains Febuxostat : 20 mg Colour : Sunset yellow Excipients : qs Tablet 2 Febuxostat Tablets 40 mg Each film coated tablet contains Febuxostat : 40 mg Colour : Titanium Dioxide Excipients : qs Tablet 3 Febuxostat Tablets 10 mg Each filmcoated tablet contains Febuxostat : 10 mg Colour : Titanium Dioxide & Iron Oxide red Excipients : qs Tablet ANTI-INFLAMMATORY/ ANALGESIC / PAIN MANAGEMENT
SL Product Formula Form 1 Mefenamic Acid dispersible Tablets 100 mg Each uncoated dispersible tablet contains Mefenamic acid IP : 100 mg Colour : Tartrazine Excipients : qs Tablet 2 Mefenamic Acid Tablets 500 mg Each uncoated tablet contains Mefenamic acid IP : 500 mg Colour : Tartrazine Excipients : qs Tablet 3 Mefanamic Acid & Paracetamol Tablet Each uncoated tablet contains Mefanamic acid IP : 500 mg Paracetamol IP : 325 mg Colour : Tartrazine Tablet 4 Paracetamol Paediatric Oral Suspension 125 mg IP Each 5 ml contains Paracetamol IP : 125 mg Flavoured syrup base : qs Colour : Erythrocine supra Suspension 5 Paracetamol Paediatric Oral Suspension 250 mg IP Each 5 ml contains Paracetamol IP : 250 mg Flavoured syrup base : qs Colour : Erythrocine supra Suspension 6 Paracetamol Tablets 1000 mg Each uncoated tablet contains Paracetamol IP : 1000 mg Excipients : qs Tablets 7 Paracetamol Soluble Tablets BP Each uncoated soluble tablet contains Paracetamol IP : 500 mg Excipients : qs Tablets 8 Tramadol Hydrochloride Tablets 100 mg Each uncoated tablet contains Tramadol Hydrochloride IP : 100 mg Excipients : qs Tablets 9 Acetaminophen & Tramadol Hydrochloride Tablets USP Each film coated tablet contains Paracetamol IP : 325 mg Tramadol HydrochlorideIP : 37.5 mg Colour : Yellow Oxide of Iron &Titanium Dioxide IP Excipients : qs Tablets 10 Paracetamol Oral Suspension 500 mg IP Each 5 ml contains Paracetamol IP : 500 mg Flavoured syrup base : qs Colour : Erythrocine Oral Liquids 11 Paracetamol Oral Suspension 100 mg IP Each ml contains Paracetamol IP : 100 mg Flavoured syrup base : qs Colour : Sunset yellow FCF Oral Liquids 12 Aceclofenac Tablets IP 100 mg Each film coated tablet contains Aceclofenac IP : 100 mg Colour : Sunset yellow Excipients : qs Tablets 13 Serratiopeptidase 10mg & Diclofenac Potassium 50 mg Each enteric coated tablet contains Serratiopeptidase 10 mg (20 000 serratiopeptidase units) Diclofenac Potassium BP 50 mg Colour : Sunset yellow Excipients : qs Tablets 14 Aceclofenac sustained release Tablets 200 mg Each film coated sustained release tablet contains Aceclofenac IP : 200 mg Colour : Sunset yellow Excipients : qs Tablets 15 Mefenamic acid suspension Each 5 ml contains Mefenamic acid IP : 100 mg Colour : Sunset yellow Flavoured syrup Base : qs Suspension 16 Diclofenac Sodium Eye/Ear drops Diclofenac Sodium BP 0.1% w/v Sorbic acid BP 0.2% w/v Sterile aqueous buffered vehicle : qs Drops 17 Diclofenac gastro-resistant Tablets IP 50 mg Each enteric coated tablet contains Diclofenac Sodium IP : 50 mg Colour : Titanium Dioxide Excipients : qs Tablets 18 Diclofenac prolonged-release Tablets BP 75 mg Each film coated prolonged-release tablet contains Diclofenac Sodium IP : 75 mg Colour : Titanium Dioxide & Iron oxide red Excipients : qs Tablets 19 Diclofenac prolonged release Tablets IP 100 mg Each film coated prolonged release tablet contains Diclofenac Sodium IP : 100 mg Colour : Titanium Dioxide & Sunset yellow Tablets 20 Oxaceprol Tablets 200 mg Each film coated tablet contains Oxaceprol : 200 mg Colour : Titanium Dioxide IP Excipients : qs Tablets 21 Piroxicam dispersible Tablets 20 mg Each uncoated dispersible tablet contains Piroxicam IP : 20 mg Colour : Sunset yellow FCF Excipients : qs Tablets 22 Serratiopeptidase and Nimesulide Tablets Each enteric coated tablet contains Serratiopeptidase IP : 10 mg ( 20,000 Serratiopeptidase units) Nimesulide BP : 100 mg Colour : Titanium Dioxide Excipients : qs Tablets 23 Ketorolac Tromethamine Eye Drops 0.5% w/v Ketorolac Tromethamine IP : 0.5% w/v Benzalkonium Chloride solution IP : 0.02% v/v Sterile aqueous vehicle : qs Drops 24 Fluticasone Nasal spray IP Each spray delivers Fluticasone Propionate IP : 50 mcg Composition : Fluticasone propionate IP : 0.05% w/v Benzalkonium Chloride solution IP : 0.02% v/v Phenyl Ethyl alcohol IP : 0.25% w/v Excipients : qs Nasal Spray 25 Mometasone Aqueous Nasal spray IP Each spray delivers Mometasone Furoate IP : 50 mcg Composition : Mometasone Fuorate IP : 0.05% w/v Benzalkonium Chloride solution IP : 0.02% v/v (as preservative) Nasal spray 26 Aceclofenac & Paracetamol Tablets Each film coated tablet contains Aceclofenac IP : 100 mg Paracetamol IP : 325 mg Colour : Sunset yellow Excipients : qs Tablets 27 Mefenamic Acid & Dicyclomine Hydrochloride Tablets Each uncoated tablet contains Mefenamic acid IP : 500 mg Dicyclomine Hydrochloride IP : 20 mg Colour : Tartrazine Excipients : qs Tablets 28 Deflazacort Tablets 6 mg Each uncoated tablet contains Deflazacort : 6 mg Excipients : qs Tablets 29 Serratiopeptidase Tablets IP 10 mg Each enteric coated tablet contains Serratiopeptidase IP : 10 mg (20,000 Serratiopeptidase units) Colour : Titanium Dioxide Excipients : qs Tablets 30 Trypsin - Chymotrypsin Tablets Each enteric coated tablet contains 1,00,000 Armour units of enzymatic activity supplied by a purified concentrate which has specified Trypsin and Chymotrypsisn Activity in a ratio approximately 6 : 1 Colour : Ponceau 4R Excipients : qs Tablets 31 Serratiopeptidase Tablets IP 5 mg Each enteric coated tablet contains Serratiopeptidase IP 5 mg (10,000 Serratiopeptidase units) Colour : Titanium Dioxide Excipients : qs Tablets 32 Paracetamol Tablets IP 500 mg Each uncoated tablet contains Paracetamol IP 500 mg Excipients : qs Tablets 33 Paracetamol Tablets IP 650 mg Each uncoated tablet contains Paracetamol IP 650 mg Excipients : qs Tablets ANTI-ULCERANTS
SL Product Formula Form 1 Antacid Oral Suspension Each 5 ml contains dried Aluminium Hydroxide gel IP : 250 mg (added as Aluminium Hydroxide paste) Activated Dimethicone IP : 50 mg Magnesium Hydroxide IP : 250 mg (added as Magnesium Hydroxide paste) Sorbitol solution(70%)IP:1.25g (Non crystallizing) Flavoured syrup base:qs Colour:Erythrosine Oral Liquids 2 Esomeprazole gastro-resistant Tablets IP 20 mg Each enteric coated tablet contains Esomeprazole Magnesium Trihydrate IP equivalent to Esomeprazole : 20 mg Colour : Titanium Dioxide Excipients : qs Tablets 3 Pantoprazole gastro-resistant Tablets IP 20 mg Each enteric coated tablet contains Pantoprazole Sodium IP equivalent to Pantoprazole : 20 mg Color : Titanium Dioxide IP & Tartrazine yellow lake Excipients : qs Tablets 4 Pantoprazole gastro-resistant Tablets IP 40 mg Each enteric coated tablet contains Pantoprazole Sodium IP equivalent to Pantoprazole : 40 mg Color : Iron Oxide red Excipients : qs Tablets 5 Rabeprazole gastro-resistant Tablets IP 20 mg Each enteric coated tablet contains Rabeprazole Sodium IP : 20 mg Colour : Iron Oxide Red Tablets 6 Sucralfate Suspension 500 mg Each 5 ml contains Sucralfate USP : 500 mg Flavoured syrup base Colour : Erythrosine Suspension 7 Sucralfate Suspension 1000 mg Each 5 ml contains Sucralfate USP : 1000 mg Flavoured syrup base Colour : Erythrosine Suspension 8 Sucralfate & Oxetacaine suspension Each 5 ml contains Sucralfate USP : 500 mg Oxetacaine BP : 10 mg Colour : Sunset yellow FCF Oral Liquids 9 Pantoprazole Sodium & Domperidone Tablets Each enteric coated tablet contains Pantoprazole Sodium IP equivalent to Pantoprazole : 20 mg Domperidone IP : 10 mg Colour : Titanium Dioxide & Sunset yellow Excipients : qs Tablets ANTI-VERTIGO
SL Product Formula Form 1 Betahistine Tablets IP 8 mg Each uncoated tablet contains Betahistine Dihydrochloride IP : 8 mg Excipients : qs Tablets 2 Betahistine Tablets IP 16 mg Each uncoated tablet contains Betahistine Dihydrochloride IP : 16 mg Excipients : qs Tablets 3 Betahistine Tablets 24 mg Each uncoated tablet contains Betahistine Dihydrochloride IP : 24 mg Excipients : qs Tablets ARTHRITIS MANAGEMENT
SL Product Formula Form 1 Etoricoxib & Thiocolchicoside Tablets Each film coated tablet contains Etoricoxib IP : 60 mg Thiocolchicoside IP : 4 mg Colour : Tartrazine lake & Titanium Dioxide IP Excipients : qs Tablets 2 Etoricoxib Tablets IP 90 mg Each film coated tablet contains Etoricoxib : 90 mg Colour : Titanium Dioxide Excipients : qs Tablets 3 Etoricoxib Tablets IP 120 mg Each film coated tablet contains Etoricoxib : 120 mg Color : Titanium Dioxide IP & Red Oxide of Iron Excipients : qs Tablets 4 Glucosamine Sulfate Potassium Chloride Tablets 750 mg Each film coated tablet contains Glucosamine Sulfate Potassium Chloride USP 750 mg equivalent to Glucosamine 444 mg Colour : Titanium Dioxide & Iron Oxide red Excipients : qs Tablets 5 Glucosamine Sulfate Potassium Chloride & Diacerin Tablets Each film coated tablet contains Glucosamine Sulfate Potassium Chloride USP equivalent to Glucosamine Sulfate 500 mg Diacerin IP : 50 mg Colour : Titanium Dioxide & Iron Oxide red Excipients : qs Tablets 6 Glucosamine Tablets USP Each film coated tablets contains Glucosamine Sulfate Potassium Chloride USP : 1500 mg Colour : Yellow Oxide of Iron & Titanium Dioxide IP Excipients : qs Tablets 7 Diacerin 50 mg, Glucosamine Sulfate Potassium Chloride 750 mg & Methyl Sulfonyl Methane 250 mg Tablets Each film coated tablet contains Diacerin IP : 50 mg Glucosamine Sulfate Potassium Chloride USP : 750 mg Methyl Sulfonyl Methane USP : 250 mg Colour : Yellow Oxide of Iron & Titanium Dioxide IP Excipients : qs Tablets BPH MANAGEMENT
SL Product Formula Form 1 Tamsulosin Hydrochloride 0.4 mg Tablets Each film coated tablet contains Tamsulosin Hydrochloride IP : 0.4 mg Colour : Titanium Dioxide IP Excipients : qs Tablets 2 Tamsulosin Hydrochloride Extended Release & Dutasteride Tablets Each film coated tablet contains Tamsulosin Hydrochloride IP : 0.4 mg ( as extended release) Dutasteride IP : 0.5 mg Colour : Yellow Oxide of Iron & Titanium Dioxide IP Excipients : qs Tablets CARDIAC DISEASE MANAGEMENT
SL Product Formula Form 1 Nifedipine prolonged - release Tablets IP 10 mg Each film coated prolonged-release tablet contains Nifedipine IP : 10 mg Colour : Erythrosine Excipients : qs Tablets 2 Nifedipine prolonged - release Tablets IP 20 mg Each film coated prolonged - release tablet contains Nifedipine IP : 20 mg Colour : Erythrosine Excipients : qs Tablets 3 Atorvastatin 10 mg & Fenofibrate Tablets Each film coated tablet contains Atorvastatin Calcium IP equivalent to Atorvastatin : 10 mg Fenofibrate IP (nano particle) : 145 mg Colour : Titanium Dioxide IP Excipients : qs Tablets 4 Atorvastatin Tablets 5 mg Each film coated tablet contains Atorvastatin Calcium IP equivalent to Atorvastatin : 5mg Colour : Red oxide of iron Excipients : qs Tablets 5 Rosuvastatin Tablets IP 5 mg Each film coated tablet contains Rosuvastatin Calcium IP equivalent to Rosuvastatin : 5 mg Colour : Yellow Oxide of Iron Excipient : qs Tablets 6 Rosuvastatin Tablets IP 10 mg Each film coated tablet contains Rosuvastatin Calcium IP equivalent to Rosuvastatin : 10 mg Colour : Titanium Dioxide & Ponceau 4R Excipient : qs Tablets 7 Rosuvastatin Tablets IP 20 mg Each film coated tablet contains Rosuvastatin Calcium IP equivalent to Rosuvastatin : 20 mg Colour : Titanium Dioxide & Tartrazine yellow Excipient : qs Tablets 8 Atorvastatin Tablets IP 10 mg Each film coated tablet contains Atorvastatin Calcium IP equivalent to Atorvastatin 10 mg Colour : Titanium Dioxide Excipients : qs Tablets 9 Atorvastatin Tablets IP 20 mg Each film coated tablet contains Atorvastatin Calcium IP equivalent to Atorvastatin 20 mg Colour : Erythrosine & Titanium Dioxide Excipients : qs Tablets 10 Atorvastatin Tablets IP 40 mg Each film coated tablet contains Atorvastatin Calcium IP equivalent to Atorvastatin : 40 mg Colour : Tartrazine Excipients : qs Tablets 11 Metoprolol Succinate Extended Release Tablets IP 25 mg Each film coated extended release tablet contains Metoprolol Succinate IP : 23.75 mg equivalent to Metoprolol Tartrate : 25 mg Excipients : qs Colour : Lake of Quinoline yellow ws Tablets 12 Metoprolol Succinate Extended Release Tablets IP 50 mg Each film coated extended release tablet contains Metoprolol Succinate IP : 47.5 mg Equivalent to Metoprolol Tartrate : 50 mg Excipients : qs Colour : Sunset yellow FCF Tablets 13 Olmesartan Medoxomil Tablets IP 40 mg Each film coated tablet contains Olmesartan Medoxomil IP : 40 mg Colour : Titanium Dioxide IP Excipients : qs Tablets 14 Telmisartan Tablets IP 20 mg Each uncoated tablet contains Telmisartan IP : 20 mg Excipients : qs Tablets 15 Telmisartan Tablets IP 40 mg Each uncoated tablet contains Telmisartan IP : 40 mg Excipients : qs Tablets 16 Metoprolol Succinate Extended Release & Telmisartan Tablets Each film coated bi-layered extended release tablet contains Metoprolol Succinate IP : 23.75 mg equivalent to Metoprolol Tartrate: 25 mg Telmisartan IP : 40 mg Excipients : qs Colour : Red Oxide of Iron & Titanium Dioxide IP Tablets 17 Metoprolol Succinate Extended Release & Telmisartan Tablets Each film coated bi-layered extended release tablet contains Metoprolol Succinate IP : 47.5 mg Equivalent to Metoprolol Tartrate : 50 mg Telmisartan IP : 40 mg Excipients : qs Colour : Yellow Oxide of Iron & Titanium Dioxide IP Tablets 18 Telmisartan 40 mg & Chlorthalidone 6.25 mg Tablets Each uncoated bi-layered tablet contains Telmisartan IP : 40 mg Chlorthalidone IP : 6.25 mg Colour : Ferric Oxide red USP Excipients : qs Tablets 19 Telmisartan 40 mg & Chlorthalidone 12.5 mg Tablets Each uncoated bi-layered tablet contains Telmisartan IP : 40 mg Chlorthalidone IP : 12.5 mg Colour : Ferric Oxide yellow USP Excipients : qs Tablets 20 Chlorthalidone Tablets IP Each uncoated tablet contains Chlorthalidone IP : 12.5 mg Excipients : qs Tablets 21 Losartan Tablets 25 mg Each film coated tablet contains Losartan Potassium IP : 25 mg Colour : Titanium Dioxide IP Excipients : qs Tablets 22 Olmesartan Medoxomil Tablets IP 20 mg Each film coated tablet contains Olmesartan Medoxomil IP : 20 mg Colour : Titanium Dioxide IP Excipients : qs Tablets 23 Losartan Tablets IP 50 mg Each film coated tablet contains Losartan Potassium IP : 50 mg Colour : Titanium Dioxide IP Excipients : qs Tablets 24 Clopidogrel Tablets IP 75 mg Each film coated tablet contains Clopidogrel Bisulphate IP equivalent to Clopidogrel 75 mg Colour : Tartrazine lake Excipients : qs Tablets 25 Torsemide Tablets IP 10 mg Each uncoated tablet contains Torsemide IP : 10 mg Excipients : qs Tablets 26 Atenolol Tablets IP 50 mg Each uncoated tablet contains Atenolol IP : 50 mg Excipients : qs Tablets 27 Amlodipine Tablets IP 5 mg Each uncoated tablet contains Amlodipine Besylate IP equivalent to Amlodipine : 5 mg Colour : Iron Oxide red Excipients : qs Tablets 28 Torsemide Tablets IP 20 mg Each uncoated tablet contains Torsemide IP 20 mg Excipients : qs Tablets 29 Torsemide Tablets 40 mg Each uncoated tablet contains Torsemide IP : 40 mg Excipients : qs Tablets DECONGESTANTS
SL Product Formula Form 1 Naphazoline Hydrochloride Ophthalmic Solution USP 0.01% w/v Naphazoline Hydrochloride USP : 0.01 % w/v Benzalkonium Chloride solution IP : 0.0 2% v/v Sterile aqueous vehicle : qs Drops 2 Phenyl Ephrine Hydrochloride & Chlorphniramine Maleate Syrup Each 5 ml contains Chlorpheniramine Maleate IP : 2 mg Phenyl Ephrine Hydrochloride IP : 5 mg Flavoured syrup base : qs Colour : Sunset yellow FCF Liquid Oral Syrup ENZYMES
SL Product Formula Form 1 Trypsin, Bromelain & Rutoside Trihydrate Tablets Each enteric coated tablet contains Trypsin BP : 48 mg Bromelain : 90 mg Rutoside Trihydrate BP : 100 mg Colour : Sunset yellow FCF Excipients : qs Total protelytic activity not less than 1095 FIP units per tablet (Papain method) Tablets EXPECTORANT / COUGH SYRUP
SL Product Formula Form 1 Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate, Expectorant Each 10 ml contains Ambroxol Hydrochloride IP : 30 mg Guaiphenesin IP : 100 mg Terbutaline sulphate IP : 2.5 mg Colour : Sunset yellow FCF Flavoured syrup base : qs Liquid Oral Syrup 2 Bromhexine Hydrochloride, Guaiphenesin, Terbutaline Sulphate, syrup Each 5 ml contains Bromhexine Hydrochloride IP : 2 mg Guaiphenesin IP : 50 mg Terbutaline sulphate IP : 1.25 mg Colour : Sunset yellow Flavoured syrup base : qs Liquid Oral Syrup HYPOTONIC
SL Product Formula Form 1 Saline Nasal solution 0.65% w/v Composition : Sodium Chloride BP 0.65% w/v Benzalkonium Chloride BP 0.03% w/v Sterile aqueous buffered vehicle : qs Nasal Drop LAXATIVE AGENTS
SL Product Formula Form 1 Lactulose Solution USP Each 5 ml contains Lactulose concentrate USP equivalent to Lactulose : 3.35 gm Flavoured syrup base : qs Colour : Sunset yellow FCF Oral Liquids LUBRICANTS
SL Product Formula Form 1 Carboxymethylcellulose Eye drops 0.5% w/v Carboxymethylcellulose Sodium IP : 0.5% w/v Benzalkonium Chloride solution 0.02% v/v Sterile aqueous vehicle Drops MUCOLYTIC AGENT
SL Product Formula Form 1 Ambroxol HCl Tablets 30 mg Each uncoated tablet contains Ambroxol Hydrochloride IP : 30 mg Excipients : qs Tablets NASAL DECONGESTANT
SL Product Formula Form 1 Azelastine Hydrochloride & Fluticasone Propionate Nasal spray Each spray delivers Azelastine Hydrochloride IP : 140 mcg Fluticasone Propionate IP : 50 mcg Composition : Azelastine Hydrochloride IP : 0.10% w/v Fluticasone Propionate IP : 0.0357% w/v Benzalkonium Chloride solution IP : 0.02% v/v (as preservative) Phenyl Ethyl alcohol IP : 0.25% v/v (as preservative) Excipients : qs Nasal Spray 2 Oxymetazoline HCl nasal solution USP 0.05% w/v Composition : Oxymetazoline Hydrochloride USP : 0.05% w/v Benzalkonium Chloride solution BP : 0.02% w/v Sterile aqueous buffered vehicle : qs Nasal Drops 3 Oxymetazoline HCl nasal solution USP 0.025% w/v Composition : Oxymetazoline Hydrochloride USP : 0.025% w/v Benzalkonium Chloride solution BP : 0.02% w/v Aqueous isotonic vehicle : qs Nasal Drops NEUROPATHIC PAIN
SL Product Formula Form 1 Mecobalamin & Pregabalin (SR) tablet Each film coated bi-layered tablet contains Mecobalamin JP : 1500 mcg Pregabalin IP : 75 mg (sustained release) Excipients : qs Colour : Ponceau 4R Tablets SYSTEMIC ALKALISER
SL Product Formula Form 1 Disodium Hydrogen Citrate Syrup Each 5 ml contains Disodium Hydrogen Citrate BP : 1.53 g Flavoured syrup base : qs Colour : Tartrazine Liquid Oral Solution VITAMINS / MINERALS
SL Product Formula Form 1 Mecobalamine Tablets 500 mcg Each film coated tablet contains Methylcobalamine JP 500 mcg Colour : Titanium Dioxide & Ponceau 4R Excipients : qs Tablets 2 Mecobalamine Tablets 750 mcg Each film coated tablet contains Methylcobalamin 750 mcg Colour : Ponceau 4R Excipients : qs Tablets 3 Mecobalamin Tablets 1500 mcg Each film coated tablet contains Mecobalamin JP : 1500 mcg Colour : Ponceau 4R Excipients : qs Tablets 4 Calcium Orotate Tablets Each film coated tablet contains Calcium Orotate : 740 mg Colour : Titanium Dioxide IP Excipients : qs Tablets 5 Ferrous Ascorbate & Folic Acid Tablets Each film coated tablet contains Ferrous Ascorbate equivalent to elemental Iron 100 mg Folic acid IP : 1.1 mg Colour : Titanium Dioxide & Ponceau 4R Excipients : qs Tablets 6 Ferrous Ascorbate & Folic acid Tablets Each film coated tablet contains Ferrous Ascorbate equivalent to elemental Iron : 50 mg Folic Acid IP : 1.5 mg Colour : Ponceau 4R & Titanium Dioxide IP Excipients : qs Tablets 7 Hematinic Syrup of Iron, Folic Acid and Vitamin B12 Each 15 ml contains Ferric Ammonium Citrate IP 160 mg (equivalent to elemental Iron : 32.8 mg) Cyanocobalamin IP : 7.5 mcg Folic acid IP : 0.5 mg Flavoured syrup base : qs Colour : Erythrosine & caramel Tablets 8 Calcium Orotate 740 mg and Vitamin D3 1000 IU Each film coated tablet contains Calcium Orotate : 740 mg Vitamin D3 : 1000 IU (as stabilized form) Colour : Titanium Dioxide IP Excipients : qs Tablets 9 Calcium Citrate Malate, Calcitriol, Magnesium & Zinc Tablets Each film coated tablet contains Calcium Citrate Malate equivalent to Elemental Calcium : 250 mg Calcitrol IP : 0.25 mcg Magnesium Hydroxide IP Equivalent to Magnesium : 100 mg Zinc Sulphate Monohydrate IP equivalent to Elemental Zinc : 4 mg Colour : Titanium Dioxide IP Excipients : qs Tablets 10 Folic acid Tablets IP 5 mg Each uncoated tablet contains Folic acid IP 5 mg Excipients : qs Tablets 11 Cholecalciferol Chewable Tablets 60,000 IU Each uncoated chewable tablet contains Cholecalciferol : 60,000 IU (as stabilized) Excipients : qs Colour : Tartrazine Tablets 12 Methylcobalamin, Alphalipoic Acid, Vitamin D3, Pyridoxine Hydrochloride & Folic Acid Tablets Each film coated tablet contains Methylcobalamin JP : 1500 mcg Alpha Lipoic acid USP : 100 mg Vitamin D3 IP : 1000 IU Pyridoxine Hydrochloride IP : 3 mg Folic acid : 1.5 mg Excipients : qs Colour : Red Oxide of Iron & Titanium Dioxide IP Tablets 13 Calcium with Vitamin D3 Tablets Each film coated tablet contains 1.25 gm Calcium Carbonate IP from an organic source (oyster shell) equivalent to Elemental Calcium : 500 mg Vitamin D3 IP : 250 IU Colour : Titanium Dioxide Excipients : qs Tablets 14 Calcium with Alfac alcidol Tablets Each film coated tablet contains 1.25 gm Calcium Carbonate IP from an organic source (oyster shell) equivalent to Elemental Calcium : 500 mg Alfacalcidol IP : 0.250 mcg Colour : Titanium Dioxide Excipients : qs Tablets 15 Ferrous Ascorbate, Folic Acid & Zinc Sulphate Tablets Each film coated tablet contains Ferrous Ascorbate equivalent to elemental Iron 100 mg Folic acid IP : 1.5 mg Zinc Sulphate Monohydrate IP : 61.8 mg Equivalent to elemental Zinc : 22.5 mg Colour : Titanium Dioxide & Ponceau 4R & Erythrosine lake Excipients : qs Tablets 16 Folic Acid, Pyridoxine Hydrochloride and Mecobalamin Tablets Each film coated tablet contains Folic acid IP : 5 mg Pyridoxine Hydrochloride IP : 20 mg Mecobalamin JP : 1500 mcg Colour : Ponceau 4R Excipients : qs Tablets 17 L-Methyl folate calcium, Pyridoxal-5-Phosphate and Mecobalamin Tablets Each film coated tablet contains L-Methylfolate calcium USP : 1mg Pyridoxal-5-phosphate : 5 mg Mecobalamin JP : 1500 mcg Colour : Ponceau 4R & Titanium Dioxide IP Excipients : qs Tablets 18 Cholecalciferol Solution 400 IU/ml Each ml contains Cholecalciferol IP (Vitamin D3) : 400 IU Palatable base : qs Colour : Sunset yellow Oral Liquids